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Stretch and/or oxygen glucose
deprivation (OGD) in an in vitro
traumatic brain injury (TBI) model
induces calcium alteration and
inflammatory cascade
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The blood-brain barrier (BBB), made up of endothelial cells of capillaries in the brain,
maintains the microenvironment of the central nervous system. During ischemia and
traumatic brain injury (TBI), cellular disruption leading to mechanical insult results to the
BBB being compromised. Oxygen glucose deprivation (OGD) is the most commonly
used in vitromodel for ischemia. On the other hand, stretch injury is currently being used
to model TBI in vitro. In this paper, the two methods are used alone or in combination,
to assess their effects on cerebrovascular endothelial cells cEND in the presence or
absence of astrocytic factors. Applying severe stretch and/or OGD to cEND cells in
our experiments resulted to cell swelling and distortion. Damage to the cells induced
release of lactate dehydrogenase enzyme (LDH) and nitric oxide (NO) into the cell culture
medium. In addition, mRNA expression of inflammatory markers interleukin (I L)-6, IL-1α,
chemokine (C-C motif) ligand 2 (CCL2) and tumor necrosis factor (TNF)-α also increased.
These events could lead to the opening of calcium ion channels resulting to excitotoxicity.
This could be demonstrated by increased calcium level in OGD-subjected cEND cells
incubated with astrocyte-conditioned medium. Furthermore, reduction of cell membrane
integrity decreased tight junction proteins claudin-5 and occludin expression. In addition,
permeability of the endothelial cell monolayer increased. Also, since cell damage requires
an increased uptake of glucose, expression of glucose transporter glut1 was found
to increase at the mRNA level after OGD. Overall, the effects of OGD on cEND cells
appear to be more prominent than that of stretch with regards to TJ proteins, NO,
glut1 expression, and calcium level. Astrocytes potentiate these effects on calcium
level in cEND cells. Combining both methods to model TBI in vitro shows a promising
improvement to currently available models.
Keywords: blood brain barrier, cEND, astrocytes, traumatic brain injury, cell stretch, oxygen-glucose deprivation,
calcium level
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Introduction
The blood-brain barrier (BBB) maintains the microenvironment
of the central nervous system (CNS). Made up of endothelial
cells of capillaries of the brain, it protects the brain from
surging fluctuations in ion concentrations and the influx of
most compounds from blood to brain. The BBB is made up of
endothelial cells that make up the barrier in the apical region.
On the other hand, it is ensheathed by astrocytes endfeet at the
basal region. In traumatic brain injury (TBI) wherein cellular
damage becomes a consequence of an extended biochemical
cascade originating from an initial mechanical insult, the BBB
is compromised. Breakdown of the BBB is a key feature of
neuroinflammatory conditions and associated with the influx of
inflammatory cells, fluids, and proteins, including complement,
and cytokines.
TBI is one of the major health problems that account for
high mortality worldwide. It results from an outward impact
that causes immediate mechanical disruption of brain tissue and
delayed pathogenic events which collectively mediate widespread
neurodegeneration (Gaetz, 2004). Experimental models, both
in vivo and in vitro are essential to improve outcome. Although,
it is difficult to cover all the spectrum of events that might
occur during TBI in one single model, an appropriate model
should be able to reproduce some of these events. Several
methods by which cells are injured to mimic TBI as it occurs
in vivo exist (Thal et al., 2013). These methods may model
focal or diffuse injury and include weight drop, fluid percussion,
controlled cortical impact cryogenic injury, barotrauma, and
acceleration/deceleration, to name a few (Morales et al.,
2005; Albert-Weissenberger and Sirén, 2010). Many in vitro
models also exist. For example, methods such as transection,
compression, hydrostatic pressure, fluid shear stress, shear strain,
and stretch injury are available (Kumaria and Tolias, 2008;
Morrison et al., 2011). Another method recently developed in
one study used a controlled scratch-induced method of injury
to brain cells (mouse neuroblastoma) cultured in multi-well
plates (Jowers et al., 2013). Here, we employed a technique that
mimics the impact that brain cells, specifically endothelial cells
of the BBB, receive during TBI. This was done by means of
stretch-induced injury of our in vitro BBB model, the murine
cerebrovascular endothelial cells cEND, a cell line which retain
expression and appropriate localization of endothelial and BBB
markers (Förster et al., 2005). The most currently used in vitro
model of ischemia is oxygen glucose deprivation (OGD) of cells
in culture. Ischemia generally proceeds after the occurrence of
head injury.
The initial head injury results to a primary insult as an
outcome of the biochemical effect of forces applied to the skull
and brain manifested in milliseconds. This is usually followed
by the development of secondary injury as a result of cerebral
hypoxia with ischemia which leads to brain swelling and edema,
activation of inflammation and blood-brain barrier leakage. Even
though the period over which secondary injury occurs varies, it is
generally observed that it can occur fromminutes after the initial
TBI to days (Gray, 2011). Any insult occurring to the brain after
the initial TBI is considered a secondary injury. Cerebral ischemia
or hypoxia is the ultimate cause of secondary injury after TBI
(Atlee, 2007). Since this is the case in vivo, i.e., that secondary
injury ensues after the initial TBI or head injury, an in vitro TBI
model should be able to replicate these two succeeding events.
The model presented in this paper shows the replication of these
events in vitro.
Mechanical stress to brain microvessels as occurs in TBI
quickly leads BBB disruption and dysfunction. During stretch
injury, nitric oxide (NO) production and actin stress fiber
formation may also be increased. This is speculated to be
a mechanism modulating BBB integrity following mechanical
injury. Meanwhile, tight junctions (TJs) create a paracellular
barrier in endothelial cells and the proteins of the occludin
and claudin family constitute the TJ strands (Förster, 2008).
Expression of occludin and claudin-5 was decreased in cEND
cells after administration of the inflammatory mediator tumor
necrosis factor (TNF)-α (Silwedel and Förster, 2006). In addition
to insult, ischemia results to a compromise in BBB integrity
which leads to an increased expression of nutrient transport
proteins such as those that transport glucose to the brain. GLUT-
1 is a member of the facilitative glucose transporter family and
is a unique transporter mediating glucose transport across the
BBB (Brockmann, 2009). Metabolic demand and regional rates
of cerebral glucose utilization play key roles in altering GLUT-
1 expression (Xiuli et al., 2005). GLUT-1 may be upregulated
at the BBB due to glutamate excitotoxicity, hypoxia, aglycemia,
and mitochondrial damage (Espinoza-Rojo et al., 2010). It is
also increased during hypoxia (Yu et al., 2010). In an in vitro
experiment, OGDwas shown to increase glut1mRNA expression
(Neuhaus et al., 2012). Although information about the effects
of OGD to GLUT-1 expression is available, data on the effects of
stretch or a combination of stretch and OGD are scarce, if not
lacking.
Mechanical injury using rapid stretch has been employed as
a method to examine TBI-induced BBB disruption in the mouse
brain microvessel endothelial cells bEnd3. Here, relevant injury
ranges thought to occur in vivo during TBI stress have been
used (Ellis et al., 1995; Weber et al., 1999). Meanwhile, OGD
has been utilized for murine cerebral (cEND) and cerebellar
(cerebEND) microvessel endothelial cells to mimic ischemia
in vitro (Kleinschnitz et al., 2011; Neuhaus et al., 2014). Both
methods have respectively been proven to be successful in
replicating head injury as initial TBI event and the succeeding
secondary injury such as ischemia. In this paper we evaluate the
effects of stretch alone or/and in combination with OGD to the
integrity of and glucose transporters expression in cEND cells as
well as their effects in cEND cells co-incubated with astrocytes.
Materials and Methods
Cell Culture
Murine brain microvascular endothelial cells from the cerebral
cortex (cEND) were isolated and immortalized as described
previously (Förster et al., 2005; Burek et al., 2012). Briefly, cortices
were isolated from 3 to 5 day-old mice, cleaned of white matter
and capillary fragments, minced, and transfected with polyoma
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middle T oncogene. The cells were grown to confluence in
tissue culture wells. These cells were then maintained in culture
with mouse endothelial cell medium (Cell Biologics, Chicago,
USA) supplemented with 50 U/mL penicillin/streptomycin and
passaged once a week. Meanwhile, the astrocyte cell line from rat
(C6 astrocytoma) was cultured using Dulbecco’s Modified Eagle’s
Medium (DMEM) (Sigma Aldrich, USA) containing 10% fetal
calf serum (FCS) and 50 U/mL penicillin/streptomycin.
Stretch Injury
Cells were grown to confluence in BioFlex 6-well culture plates
with collagen-coated silastic membranes (Flexcell International
Corp). Upon confluence, cells were made to differentiate in
medium containing 1% fetal calf serum (FCS) for 24 h. Biaxial
stretch was applied to the cells using the Cell Injury Controller
II system (Virginia Commonwealth University) with 50ms pulse
duration. During cell deformation, the degree of stretch can be
varied depending on the amount of pressure applied to the well.
This can range from 1.8 to 4.5 psi producing 20% (5.5mm),
35% (6.5mm), and 55%, (7.5mm) stretch which correspond to
mild, moderate, and severe stretch, respectively (Ellis et al., 1995;
Weber et al., 1999). For this study, cells were subjected only
to severe stretch injury since mild and moderate stretch fail to
induce LDH release in cEND cells (Salvador et al., 2013). After
cell injury, cells were made to recover in the 37◦C incubator for
15 and 30min, and 1, 2, 4, 8, and 24 h. Cells that were allowed to
recover for 15min were subjected to oxygen glucose deprivation
(OGD).
Oxygen Glucose Deprivation (OGD)
After allowing the cells to differentiate in medium containing
1% fetal calf serum (FCS) for 24 h, the medium was replaced
with DMEM lacking D-glucose. The cells were then incubated
in a hypoxic incubator with the following conditions: 1% O2,
5% CO2, saturated humidity atmosphere and 37
◦C for 4 h as
previously described (Kleinschnitz et al., 2011). After OGD, cells
were either used as samples or are re-oxygenated for 20 h. Prior
to re-oxygenation, cells were washed in PBS and the medium was
replaced with medium containing glucose and 10% FCS.
Cell Membrane Integrity
Dye exclusion is a widely used indicator of cell injury. After
subjecting cells to stretch, they were stained with Image-iT R©
DEAD Green™ viability stain (Life Technologies), a dye that
penetrates injured cells and binds to the DNA in the nuclei,
producing a green fluorescence. Dye was added to the cells
immediately after injury to a final concentration of 100 nm and
viewed under the microscope.
Lactate Dehydrogenase (LDH) Enzyme Release
LDH is an enzyme released by the cell upon damage or
lysis and is therefore an indicator of cell membrane integrity.
The evaluation of extracellular LDH activity is a measure of
cytotoxicity, since this cytosolic enzyme can be released only
following the disruption of cell membranes. After cell injury,
cells were made to recover in the 37◦C incubator for 15min,
30min, 1, 2, 4, 6, 8, and 24 h and culture medium was collected
at each time point. Afterwards, the cells were lysed to collect
and measure total releasable LDH. The same has been done for
cells subjected to OGD and a combination of stretch and OGD.
Next, LDH released from the cells into themediumwasmeasured
using the LDH Cytotoxicity Detection Kit++ (Roche) according
to manufacturer’s instructions. LDH release was expressed as
percentage of the total releasable LDH.
Nitric Oxide (NO) Production
After subjecting the cells to stretch, 1ml of the medium
was taken from each well and ultra-filtered through a 10,000
molecular weight cut-off (MWCO) filter (Thermo Scientific).
Nitric oxide (NO) production was detected by means of the
Griess reaction using the Nitric Oxide (total) detection kit (Enzo
Life Technologies).
Tight Junction Proteins Expression
Traumatic brain injury alters the expression of tight junction
proteins in the cell. The mRNA expression and the protein
expression levels of claudin-5 and occludin were examined.
Western Blotting
After subjecting cells to stretch injury, they were washed twice
with ice cold phosphate buffer saline (PBS) and harvested
from the wells through lysis using RIPA-Buffer (50mM Tris
pH 8.0, 150mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate,
1% NP40) containing protease inhibitor cocktail (Roche) and
Phenylmethylsulfonylfluoride (PMSF). After harvesting cells on
ice, they were sonicated 10 × for 0.5 s on ice. Samples were
then mixed with Laemmli buffer with 5% β-mercaptoethanol.
They were denatured at 95◦C for 5min. Proteins were separated
through 10% SDS PAGE minigels and electrophoretically wet-
transferred using a Mini Trans-Blot Electrophoretic Transfer
Cell (BioRad) to a PVDF membrane. Following transfer, the
membrane was washed with Dulbecco’s phosphate buffered
saline (PBS) (Sigma Aldrich) and blocked in 5% non-fat dry
milk for 1 h and incubated at 4◦C overnight in 0.5% BSA-
PBS containing claudin-5 (1:400), occludin (1:400) or beta actin
(1:2500). Afterwards, the membrane was washed four times
for 15min each with PBS and incubated at room temperature
in 1% BSA-PBS containing the secondary antibody. Next, the
membrane was washed three times for 15min each with PBS-
T, incubated for 2min in ECL solution and then imaged using
Fluorchem FC2 software (Biozym) with the MultiImage II
imager.
Quantitative Real Time Polymerase Chain Reaction
(qRT-PCR)
Total RNA was isolated from lysed cells and purified according
to manufacturer’s instructions (Nucleospin RNA II, Machery-
Nagel, No. 740955). cDNA was generated using the High
Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems,
No. 4368814). 1µg cDNA was used for qRT-PCR with Brilliant
III Ultra-Fast QPCR Master Mix (Agilent, No. 600880). The
following TaqMan Gene Expression Assay primers were
used: ActB (Mm01205647_g1), Cldn5 (Mm00727012_s1),
Ocln (Mm00500912_m1), IL6 (Mm00446190_m1), IL1a
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(Mm00439620_m1), TNFa (Mm00443260_g1), CCl2
(Mm00441243_g1), glut-1 (mM01192270_m1).
Calcium Assay
The amount of calcium in the cells as affected by stretch and
OGD was assessed with the Fluo-4 Direct™ Calcium Assay Kit
(Invitrogen, No. F10471). Prior to stretch and OGD experiments,
cEND cells were co-incubated with medium from stretched or
OGD-subjected C6 cells for 24 h. Following stretch and/or OGD
treatments, the cells were trypsinized, harvested, pelleted by
centrifugation at 200×g (1000 rpm) for 3min and transferred to
a 96-well plate, each sample in triplicate. 1% 5mg/ml isradipine
(Abcam Biochemicals, UK) was used as a blocker (control). The
assay was conducted according to manufacturer’s instructions.
Fluorescence was measured 494 nm excitation and emission at
516 nm using the Tecan GENios Microplate Reader (MTX lab
Systems, Inc).
Permeability Measurement
Prior to seeding the cells, the BioFlex 6-well culture plates
(Flexcell International Corp) were coated with 3ml of 0.25mg/ml
biotin conjugated-gelatin overnight then washed twice with PBS
(Dubrovskyi et al., 2013). After stretch and OGD experiments,
permeability was measured through fluorescein isothiocyanate
(FITC)-avidin assay. Briefly, 25µg/ml FITC-avidin was added to
cells for 3min. Unbound FITC-avidin was removed by washing
twice with PBS. Next, the elastic bottoms of the wells were excised
with a scalpel and mounted onto polystyrene 6-well plates. The
membranes were then covered with 1ml of PBS. Finally, the
fluorescence was measured using a multilabel plate reader.
Statistical Analysis
Data were analyzed through Sigma Plot (Systat Software Inc,
California) using ANOVA with pairwise comparison, Holm-
Sidak method.
Results
Cell Stretch Destroys Cell Membrane Integrity
To assess the effects of stretch in brain endothelial cell, murine
cerebrovascular endothelial (cEND) cells were grown on collagen
pre-coated 6-well flexible bottomed culture plates (57.75 cm2)
and subjected to stretch injury using the cell stretcher device.
Afterwards, they were examined under the microscope for
morphological effects of stretch-induced injury.
Control cells which were not subjected to injury appear
as regularly shaped cEND cells without any indication of cell
swelling or distortion (Figure 1). On the other hand, deformation
could be observed for cells subjected to low, moderate, and severe
stretch (Figure 1). After the cells were stretched with a peak
pressure between 3.5 and 4.5 psi corresponding to severe stretch,
they appeared markedly retracted, swollen, and deformed with
notable intercellular spaces (Figure 1). Moreover, when viability
stain (100 nmfinal concentration) was applied to the cells, the dye
was excluded frommost of the control cells, thus, only a few of the
cells were stained (Figure 1). However, most of the cells that were
subjected to stretch took up the dye (Figure 1). The viability stain
used is a dye impermeant to healthy cells that becomes permeant
when the plasmamembrane integrity of the cells is compromised.
Cell Stretch Leads to Increased LDH Secretion
Lactate dehydrogenase is an enzyme used to indicate the
occurrence of cytotoxicity in cells. The release of LDH in the
supernatant of the cell culture medium indicates cell damage.
It was observed among cells subjected to severe stretch that the
amount of LDH released by the cells into the cell culture medium
significantly increased immediately (0min), 15, and 30min, 1, 2,
4, 8, and 24 h after stretch injury (Figure 2) as compared to cells
that were not subjected to stretch or were subjected to low and
moderate stretch (p < 0.05). Moreover, cells that were stretched
(low, moderate, and severe) and allowed to recover for 24 h post-
injury released significantly higher amount of LDH compared to
other time points.
LDH release of cells that were subjected to severe stretch and
made to recover for 15min was compared to cells subjected to
OGD and cells that underwent both conditions. It was observed
that stretch released significantly higher LDH compared to no
stretch control as well as OGD. Meanwhile, the combination
of stretch and OGD generated a significantly higher amount of
LDH compared to no stretch control, stretched cells, and cells
subjected to OGD (Figure 3).
Stretch and OGD in cEND Cells Induce
Inflammatory Cascade and Alter NO Secretion
In order to assess the characteristics of inflammatory response in
our in vitro model, inflammatory cytokine production in cEND
cells was assessed at the mRNA level. cEND cells have been
previously shown to secrete various chemokines into the cell
culture medium (Burek et al., 2014). IL6 is believed to be among
the best markers of disease severity in patients with systemic
inflammation fromwhatever cause (Reinhart et al., 2002). Results
show that greatest mRNA expression of inflammatory markers
interleukin (IL)-6, IL-1α, chemokine (C-C motif) ligand 2
(CCL2) and tumor necrosis factor (TNF)-α in cells subjected to
stretch was after 24 h (p < 0.005). Stretched cells induced CCL2
and TNF-α expression greater than those subjected to OGD
(p < 0.005); whereas those subjected to OGD induced greater
IL1-α and IL-6 expression than the stretched cells (p < 0.005)
(Figure 4).
Nitric oxide (NO) is a major mammalian secretory product
that initiates host defense and accumulates in the brain after
injury. We detected total NO production in the cells. Results of
the assay showed that a significantly higher amount of NO is
produced by cEND cells subjected to OGD and OGD combined
to stretch compared to all other treatments (p < 0.005)
(Figure 5).
Stretch and OGD Induce Decrease of Tight
Junction Proteins Expression and Increase in
Glut-1 Level
Tight junction proteins are important in the maintenance
of blood-brain barrier (BBB) permeability. Once the BBB is
compromised or damaged, the expression of tight junction
proteins changes. Therefore, we analyzed the expression of
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FIGURE 1 | Microscopic examination of unstretched and stretched
cEND cells. Under the light microscope, unstretched cEND cells are
compact and spindle-shaped while severely stretched cells appear swollen,
deformed, and retracted (indicated by arrows). Meanwhile, fluorescence
microscopy shows that more cells take up the viability stain with increased
stretch. Magnification 100X.
FIGURE 2 | Lactate dehydrogenase (LDH) enzyme release into the
cell culture medium after stretch injury. LDH released into the
culture medium was measured at various time points after stretch
induced injury. LDH was expressed as a percent of the total releasable
LDH (LDH in media plus cells). Data are mean values ± SEM. The n
for every time point is 5. Severely stretched cEND cells released a
significantly greater amount of LDH as compared to unstretched cells at
all time points (*p < 0.05).
occludin and claudin-5 both at the protein and mRNA levels.
Western blot and subsequent densitometric analyses show that
occludin protein expression significantly decreased (p < 0.005)
after subjecting cells to stretch as well as to OGD and a
combination of both in comparison to no stretch control. On
the other hand, claudin-5 protein expression decreased after
subjecting cells to stretch as well as OGD, a combination of
both, and with subsequent re-oxygenation (RO) compared to
control but not significantly (Figure 6). Meanwhile, qPCR results
show no change in the mRNA expression of occludin among the
various treatments. In contrast, mRNA expression of claudin-
5 in cells subjected to a combination of OGD and stretch,
OGD with subsequent RO, and OGD combined with stretch and
subsequent RO decreased significantly (p < 0.005) compared
to cells subjected to stretch and made to recover for 15min and
OGD (Figure 7).
Quantitative real time polymerase reaction (qPCR) results
show that the mRNA expression of glut1 significantly increased
in cEND cells during OGD as well as a combination of OGD and
stretch (p < 0.005) compared to all other treatments (Figure 8).
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FIGURE 3 | Lactate dehydrogenase (LDH) enzyme release into the
cell culture medium in the various treatment conditions. LDH
generated after stretch, OGD, a combination of both and successive
reoxygenation was measured. LDH was expressed as a percent of the
total releasable LDH (LDH in media plus cells). Data are mean values ±
SEM, n = 3. ∗, ¤, $ p < 0.05 compared to no stretch, stretched, and
OGD, respectively. OGD, oxygen glucose deprivation; RO,
re-oxygenation.
FIGURE 4 | mRNA expression of inflammatory markers in
stretched cEND cells. Values are the means (± SEM) of 3
independent experiments. Statistical significance was evaluated using
One-Way ANOVA (Holm-Sidak method) ∗, $, U, ¤, ø, # p < 0.005
compared to no stretch, stretched 24 h, OGD, OGD + Stretch, OGD +
RO, OGD + Stretch + RO, respectively. OGD, oxygen glucose
deprivation; RO, re-oxygenation. (A–D) Selected inflammatory markers
involved in TBI and ischemia.
Frontiers in Cellular Neuroscience | www.frontiersin.org 6 August 2015 | Volume 9 | Article 323
Salvador et al. Stretch/OGD alter/s calcium and inflammation
FIGURE 5 | Total nitric oxide (NO) production in cEND cells. Values are the means (± SEM) of 3 independent experiments. Statistical significance was evaluated
using One-Way ANOVA (Holm-Sidak method), *p < 0.005 compared to all the rest of the treatments. OGD, oxygen glucose deprivation; RO, re-oxygenation.
FIGURE 6 | Western blot and densitometric analyses of tight junction
proteins in cEND cells. Values are the means (± SEM) of 4–5 independent
experiments normalized to β-actin. Statistical significance was evaluated
using One-Way ANOVA (Holm-Sidak method), ∗, U, $ p < 0.005 compared
to no stretch control, OGD + Stretch + RO, and OGD + RO, respectively.
OGD, oxygen glucose deprivation; RO, re-oxygenation.
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FIGURE 7 | qPCR analysis of tight junctions mRNA expression in cEND
cells. Values are the means (± SEM) of 6 independent experiments
normalized to β-actin. Statistical significance was evaluated using One-Way
ANOVA (Holm-Sidak method), ∗, # p < 0.005 compared to stretched 15′ and
OGD, respectively. OGD, oxygen glucose deprivation; RO, re-oxygenation.
FIGURE 8 | qPCR analysis of glut1 mRNA expression in cEND cells.
Values are the means (± SEM) of 4 independent experiments normalized to
β-actin. Statistical significance was evaluated using One-Way ANOVA
(Holm-Sidak method), ∗, #, § p < 0.005 compared to all, OGD + RO, and
OGD + Stretch + RO, respectively. OGD, oxygen glucose deprivation; RO,
re-oxygenation.
Stretch and OGD Alter Calcium Ion Levels in
cEND Cells and is Influenced by Glial Cells C6
Prior to subjecting cEND cells to stretch and/or OGD, glioma
cells C6 were subjected to severe stretch and/or 4 h of OGD.
Cell culture medium was collected from the C6 cells, added to
the cEND cell culture and incubated for 24 h prior to further
handling in order to generate interaction between endothelial
cells and astrocyte-secreted factors. OGD and a combination of
stretch and OGD significantly increased calcium concentration
in both cEND cells and cEND cells incubated in medium of
C6 cells subjected to stretch or OGD, compared to unstretched
cells. On the other hand, stretch significantly decreased calcium
concentration in both cEND cells and cEND cells with C6
medium compared to unstretched cEND cells. Incubation of
cEND cells with medium from C6 cells subjected to OGD prior
to OGD and stretch combined with OGD resulted to significantly
higher calcium levels, suggesting influence of astrocytes on
cEND cells (Figure 10). Meanwhile, both stretch injury and
OGD significantly increased calcium concentration in C6 cells
(Figure 11). Addition of the calcium blocker isradipine decreased
calcium ion concentration in all samples (Data not shown).
Stretch and OGD Increase Permeability of
Endothelial Monolayer
Upon subjecting the cells to stretch and/or OGD with or
without re-oxygenation, quantification of FITC-labeled avidin
bound to the biotinylated gelatin-coated membrane was done to
assess permeability. Results show that OGD and a combination
of stretch and OGD increased the permeability of the cEND
monolayer significantly (Figure 12). Stretch also increased the
permeability although not significantly. When the cells were re-
oxygenated after OGD and stretch, the permeability reverted to
the same level as that of the cells that did not undergo any
treatment.
Discussion
We report the effects of stretch injury as an in vitro model
for traumatic brain injury (TBI) (Salvador et al., 2013) alone
or combined with oxygen glucose deprivation (OGD) in the
in vitro model of the blood brain barrier (BBB), cerebrovascular
brain endothelial cells cEND as well as the expression of glucose
transporter GLUT-1 in these cells. OGD has been used to
mimic stroke conditions in vitro using the brain microvascular
endothelial cell cerebEND in combination with astrocytes
(Neuhaus et al., 2014). On the other hand, stretch-induced injury
has been employed in themurine brainmicrovascular endothelial
cells bEND3 (Berrout et al., 2011). To our knowledge, however,
no study that uses a combination of both or comparing the effects
of both can be found in the literature and is thus the aim of our
study.
TBI is damage to the brain as a result of an external
mechanical force i.e., rapid acceleration or deceleration, blast
waves, crush, an impact, or penetration by a projectile (Maas
et al., 2008). It involves twomechanisms of injury. Primary injury
results from the immediate mechanical disruption of brain tissue
that occurs at the time of exposure to the external force. It
includes contusion, damage to blood vessels and axonal shearing.
Meanwhile, secondary injury evolves over minutes to months
after the primary injury and is the result of cascades of metabolic,
cellular, and molecular events that ultimately lead to brain cell
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FIGURE 9 | Stretch induces cellular disruption leading to
inflammatory cascade. Subjecting murine cerebrovascular endothelial cells
cEND to stretch, alone, or in combination with oxygen glucose deprivation
(OGD) results to compromise of cell membrane integrity. Damage to the cell
membrane decreases expression of tight junction proteins. Cellular disruption
brings about production of reactive oxygen species (ROS), nitric oxide (NO),
and lactate dehydrogenase enzyme (LDH), and could also lead to the
opening of calcium ion channels inducing the inflammatory cascade.
FIGURE 10 | Stretch and OGD alter calcium ion levels in cEND
and cEND + C6 cells. Calcium concentration relative to that
measured in unstretched cEND cells (100%). Values are the
percentages of the means (± SEM) of 4 independent experiments.
Statistical significance was evaluated using One-Way ANOVA
(Holm-Sidak method), **p < 0.001 compared to unstretched cEND
cells, s p < 0.001. OGD, oxygen glucose deprivation; RO,
re-oxygenation.
death, tissue damage, and atrophy (Gaetz, 2004; Cernak, 2005). In
this paper, stretch was used to simulate the primary mechanical
disruption and OGD as a model of ischemia to mimic secondary
injury. Inflicting cEND cells with stretch injury was shown to
alter their morphology as a result of deformation. As a result of
injury, production of cytotoxicity marker lactate dehydrogenase
enzyme (LDH), inflammatory markers interleukin (IL)-6, IL-1α,
chemokine (C-C motif) ligand 2 (CCL2) and tumor necrosis
factor (TNF)-α and total nitric oxide (NO) was induced in the
cells. In addition, disruption of cell permeability was shown by
microscopy as well as reduction in the amount of tight junction
proteins occludin and claudin-5 produced. These parallel some
events that occur during primary and secondary injuries in actual
TBI (Figure 9).
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FIGURE 11 | Stretch and OGD alter calcium ion levels in C6 cells.
Values are the percentages of the means relative to non-stretched C6 cells
(± SEM) of 4 independent experiments. Statistical significance was evaluated
using One-Way ANOVA (Holm-Sidak method). **p < 0.001 compared to
unstretched cEND cells. OGD, oxygen glucose deprivation; RO,
re-oxygenation.
FIGURE 12 | Measurement of endothelial monolayer permeability
under stretch and/or OGD conditions. The quantification of FITC-labeled
avidin bound to the biotinylated gelatin-coated membrane was done to
assess permeability of the cell monolayer. FITC fluorescence was measured
using a multilabel plate reader. Values are the percentages of the means
relative to non-stretched cells (± SEM), n = 3. Statistical significance
was evaluated using One-Way ANOVA (Holm-Sidak method), *, $, ø, §,
¤ p < 0.005 compared to no stretch, stretched 15′, OGD + RO, Stretch +
OGD + RO, and control (blank), respectively. OGD, oxygen glucose
deprivation; RO, re-oxygenation. Blank control refers to uncoated wells.
In our experiments, LDH was significantly increased in the
cells subjected to stretch compared to control cells. LDH activity
in the culture medium is as an indicator of cell membrane
integrity, and thus a measurement of cytotoxicity (Haslam et al.,
2000; Wolterbeek and van der Meer, 2005). Therefore, an
increase in the amount of LDH released by the cells is tantamount
to cell disruption. Initially, our results showed that a greater
degree of stretch generated the highest LDH release. For this
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reason, we used severe stretch in the succeeding experiments.
It has already been shown in porcine microvascular endothelial
cells that increased stretch injury results to stretch-dependent
increase in LDH (Gidday et al., 1999). In the same manner,
OGD has been found to generate increased LDH expression in
rat endothelial cells (Ceruti et al., 2011). In comparing LDH
release among stretch-, OGD- and stretch plus OGD-subjected
cells, we observed greater LDH release in all three compared
to control. However, stretched as well as stretched and OGD-
subjected cells generated more LDH compared to those subjected
to OGD. These results indicate injury outcome in both methods
used, but in varying degrees.
In as much as cell disruption took effect with the application
of stretch, we anticipated an inflammatory cascade. Indeed, our
results demonstrated such. For instance, our model exhibited
increased IL-6 release in stretched cells after 24 h. Previous
studies also proved that to be the case. IL-6, a major inflammatory
mediator, is one of the first cytokines produced after TBI.
Expression of IL-6 in the brain is low under physiological
conditions. However, levels are elevated in a large number of
human central nervous system (CNS) disorders (Lucas et al.,
2006). After severe TBI, IL-6 is increased in the cerebrospinal
fluid (CSF) (Kossmann et al., 1995; Bell et al., 1997). It was
reported in a study of canine TBI that control brains showed
little expression of inflammatory cytokines in the brain. On the
other hand, immunoreactivity for pro-inflammatory cytokines
such as IL-1β, IL-6, and TNF-α has been identified in the injured
brains. It has also been shown that TBI activates an inflammatory
reaction initiated by the release of pro-inflammatory cytokines
such as IL-1β, IL-6, and TNF-α (Yu et al., 2011). IL-1 expression is
rapidly increased in response to experimental insults such as head
injury, cerebral ischemia, seizures, or CNS infections (Mogi et al.,
1994; Touzani et al., 1999). In our study, IL-1α was increased in
cells subjected to stretch after 24 h post-injury as well as OGD
and a combination of both. IL-1 occurs in several forms with IL-
1α and IL-1β as the most studied and well-known forms. IL-1α
is the predominant form in mice. For this reason, it is the form
included in the experiment. IL-1α is a pro-inflammatory cytokine
identified to be important in inflammatory response following
TBI. It is important in the regulation of the inflammatory
response as well as the balance between pro-inflammatory and
anti-inflammatory cytokines (Arend, 1991; Dinarello, 1991). IL-
1α and IL-1β differ in many ways. IL-1β is secreted and circulates
systemically while IL-1α is generally associated with the plasma
membrane of the producing cells and acts locally. In addition,
IL-1β is mainly produced by monocytes and macrophages while
IL-1α is expressed by keratinocytes and endothelial cells (Sims
and Smith, 2010). IL-1 triggers inflammatory reactions. This
leads to recruitment of leukocytes, disruption of BBB and
formation of edema. In addition, it induces the production
of other interleukins, prostaglandins, histamine, thromboxane,
chemokines and adhesion molecules and exerts multiple effects
in neuronal, glial and endothelial cells (Hopkins and Rothwell,
1995; Rothwell and Hopkins, 1995). Similarly, TNF-α was
markedly increased in stretched cells 24 h post-injury. Ischemic
or traumatic brain injury induces synthesis of TNF-α precursor
peptide, pro TNF-α, leading to the release of soluble TNF-α
into extracellular space (Shohamia et al., 1999). TNF-α plays
a significant role in calcium signaling, which is important for
increased excitotoxicity and neuroinflammation. It was found
out that TNF-α depresses calcium signal communication in BBB
endothelial cells, by reducing gap junctional coupling and by
inhibiting triggered ATP release (Vandamme et al., 2004).
NO affects different processes in vascular endothelial cells
(Blecharz et al., 2014). Our experiments showed increased NO
production after OGD but not stretch. NO accumulates in the
brain after injury. It was reported that NO accumulates in the
brain after injury in two time periods: immediately after injury
and then, several hours-days later. It can be produced by nearly
all tissue of the body but physiologically, its expression is found
highest in the brain. NO levels are significantly increased but
very transiently and then decreased significantly within 30min
of controlled cortical impact (CCI) TBI in rats (Cherian et al.,
2004). The production of nitric oxide is catalyzed by nitric oxide
synthases (NOS). Three isoforms of NOS exist: the constitutive
(neuronal and endothelial) and inducible NOS. Endothelial NOS
(eNOS) synthesizes NO only when calcium ion concentration
is elevated (Förstermann et al., 1998). Brain ischemia triggers a
cascade of events leading to the activation of Ca2+-dependent
NOS isoforms. Nitric oxide biosynthesis is a key factor in the
pathophysiological response of the brain to hypoxia-ischemia
(Bolaños and Almeida, 1999). Stretch injury in mouse brain
microvessel endothelial cells (bEnd3) has also been shown to
increase calcium influx and NO production (Berrout et al., 2011).
TBI alters NO synthesis rates and brain tissue NO levels (Ahn
et al., 2004). It is an endothelium-relaxing factor and a cerebral
and systemic vasodilator (Faraci et al., 1994). It contributes to a
constant state of partial dilation. Therefore, an increase in NO
production would increase cerebral blood flow after TBI. In the
ischemic cerebral cortex, NO production was observed to have
rapidly and transiently increased after focal cerebral ischemia
(Kader et al., 1993).
Our in vitro model of the blood brain barrier, cEND,
demonstrates characteristics of a suitable model of the BBB
(Förster et al., 2005). The BBB is formed by brain capillary
endothelial cells with tight junctions (TJs) as its most important
structural components (Rubin and Staddon, 1999). Claudin-5 is
one of the TJ proteins critical in sealing the paracellular space of
the BBB (D’Atri and Citi, 2002). It plays an important role in the
permeability of the blood brain barrier. Hence, its degradation
could result in BBB breakdown (Förster, 2008). OGD reduced
the expression of TJ proteins and transendothelial resistance in
cEND cells (Kleinschnitz et al., 2011). This could also be depicted
in our use of stretch andOGDwith decreased protein expressions
of claudin-5 and occludin.
Permeability is an important measure of BBB integrity (Audus
et al., 1990). During injury when the BBB is disrupted, the
permeability of the endothelium is increased. It is thus important
to investigate the functionality of the endothelial monolayer in
an in vitro model system that targets to reproduce the events
that occur in vivo during TBI and ischemia. The increased
permeability of the endothelial monolayer during stretch and
OGD in our in vitro model demonstrates BBB disruption. The
tight junctions present in intact endothelium limit the diffusion
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of molecules between the cells and the low levels of pinocytic
activity restrict the intracellular transport of molecules (Audus
and Borchardt, 1991). Under certain conditions such as injury,
the low permeability state of the BBB is altered, allowing
the influx of macromolecules which could lead to neuronal
damage.
During TBI, there is massive influx of calcium ions into
the cells of the CNS. It has been shown that total cell calcium
increases in astrocytes after injury (Hovda et al., 1992; Fineman
et al., 1993; Rzigalinski et al., 1997). In our experiments,
stretch and OGD as well as a combination of both, increased
calcium ion levels in C6 cells. A reversion to levels similar
to that of control was observed after re-oxygenation and re-
supplementation with glucose. This is in accordance to published
results that the levels of calcium concentration in astrocytes
increase after stretch injury and return to normal levels by
15min post-injury (Rzigalinski et al., 1998). The same has
been observed for astrocytes that were subjected to ischemic
injury (Cheung et al., 1986; Choi, 1988). Meanwhile, it has
been reported that mechanical injury of brain endothelial cells
induces a rapid influx of calcium immediately after injury.
However, the increase was only small and transient in the
absence of extracellular calcium as opposed to when cells were
supplied with extracellular calcium (Berrout et al., 2011). This
suggests that the increase in calcium levels is due to calcium
influx and not calcium release. In our experiments, the levels
of calcium ions decreased in cEND cells after stretch, followed
by 15min recovery. The amount of time wherein the cells
where made to recover possibly contributed to the decreased
calcium level. Activation of tyrosine kinase receptors results to
calcium influx in bovine aortic endothelial cells (Munaron and
Fiorio Pla, 2000). Meanwhile, reactive astrocytes were shown to
express functional tyrosine kinase receptors following insult to
the cerebral cortex (McKeon et al., 1997) which could be the
reason for increased calcium concentration in the cEND cells
incubated in medium of injured C6 cells compared to cEND cells
alone.
Traumatic brain injury (TBI) involves a cascade of
morphological and physiological events. Most in vivo models
of TBI meet the criteria of reproducing such occurrences
(Morales et al., 2005; Albert-Weissenberger and Sirén, 2010).
In order for an in vitro system to be suitable as a model, it
should also be able to mimic these incidents (Kumaria and
Tolias, 2008; Morrison et al., 2011). Here, we report the effects
of stretch alone or in combination with OGD to an existing
in vitro blood-brain barrier model (BBB), cEND. The use of
both stretch and OGD leads to cellular disruption, decrease
in tight junction proteins and increase inflammatory markers
expression. Overall, the effects of OGD appear to be more
prominent than that of stretch. OGD decreased expression of
tight junction proteins claudin-5 and occludin, and increased
expression of NO and glucose transporter GLUT-1 more
significantly than stretch. Nonetheless, there are specific
effects brought about by stretch such as a marked increase in
TNF-α expression which is not the case for OGD. Therefore,
a combination of both enhances the replication of events
in TBI, an important feature sought for in an in vitro TBI
model.
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